JP2023530112A5 - - Google Patents
Info
- Publication number
- JP2023530112A5 JP2023530112A5 JP2022576792A JP2022576792A JP2023530112A5 JP 2023530112 A5 JP2023530112 A5 JP 2023530112A5 JP 2022576792 A JP2022576792 A JP 2022576792A JP 2022576792 A JP2022576792 A JP 2022576792A JP 2023530112 A5 JP2023530112 A5 JP 2023530112A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- mean
- mean increase
- score
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026060810A JP2026117025A (ja) | 2020-06-14 | 2026-04-02 | 遅発型ポンペ病を処置するための組成物及び方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038857P | 2020-06-14 | 2020-06-14 | |
| US63/038,857 | 2020-06-14 | ||
| US202063076037P | 2020-09-09 | 2020-09-09 | |
| US63/076,037 | 2020-09-09 | ||
| US202163147629P | 2021-02-09 | 2021-02-09 | |
| US63/147,629 | 2021-02-09 | ||
| US202163157490P | 2021-03-05 | 2021-03-05 | |
| US63/157,490 | 2021-03-05 | ||
| PCT/US2021/037111 WO2021257409A1 (en) | 2020-06-14 | 2021-06-11 | Compositions and methods for treating late-onset pompe disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026060810A Division JP2026117025A (ja) | 2020-06-14 | 2026-04-02 | 遅発型ポンペ病を処置するための組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530112A JP2023530112A (ja) | 2023-07-13 |
| JP2023530112A5 true JP2023530112A5 (enExample) | 2024-06-18 |
Family
ID=76797137
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576792A Pending JP2023530112A (ja) | 2020-06-14 | 2021-06-11 | 遅発型ポンペ病を処置するための組成物及び方法 |
| JP2026060810A Pending JP2026117025A (ja) | 2020-06-14 | 2026-04-02 | 遅発型ポンペ病を処置するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026060810A Pending JP2026117025A (ja) | 2020-06-14 | 2026-04-02 | 遅発型ポンペ病を処置するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12533396B2 (enExample) |
| EP (1) | EP4164678A1 (enExample) |
| JP (2) | JP2023530112A (enExample) |
| KR (1) | KR20230025874A (enExample) |
| CN (1) | CN115916245A (enExample) |
| AU (1) | AU2021293021A1 (enExample) |
| BR (1) | BR112022025314A2 (enExample) |
| CA (1) | CA3182409A1 (enExample) |
| IL (1) | IL299015A (enExample) |
| MX (1) | MX2022016019A (enExample) |
| TW (1) | TW202214302A (enExample) |
| WO (1) | WO2021257409A1 (enExample) |
| ZA (1) | ZA202300544B (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
| JP5137814B2 (ja) | 2005-04-06 | 2013-02-06 | ジェンザイム・コーポレーション | 治療ターゲティングのための酸不安定リンカーを介するｐｅｇおよびポリシアルリソソーム酵素のコンジュゲート |
| CN102978185B (zh) | 2007-01-18 | 2015-02-11 | 建新公司 | 包含氨基氧基基团的寡糖及其轭合物 |
| EP3608330B1 (en) * | 2008-12-16 | 2022-11-09 | Genzyme Corporation | Synthetic intermediates for preparing oligosaccharide-protein conjugates |
| US8883979B2 (en) | 2012-08-31 | 2014-11-11 | Bayer Healthcare Llc | Anti-prolactin receptor antibody formulations |
| IL299470B2 (en) | 2015-12-30 | 2026-05-01 | Amicus Therapeutics Inc | Improved acid alpha-glucosidase for the treatment of Pompe disease |
| CA3019354A1 (en) | 2016-03-30 | 2017-10-05 | Amicus Therapeutics, Inc. | Method for selection of high m6p recombinant proteins |
| KR102618519B1 (ko) | 2016-03-30 | 2023-12-28 | 아미쿠스 세라퓨틱스, 인코포레이티드 | 재조합 산 알파-글루코시다제를 포함하는 제형 |
| EP4100120A1 (en) | 2020-02-08 | 2022-12-14 | Genzyme Corporation | Compositions and methods for treating pompe disease |
-
2021
- 2021-06-11 BR BR112022025314A patent/BR112022025314A2/pt unknown
- 2021-06-11 CA CA3182409A patent/CA3182409A1/en active Pending
- 2021-06-11 KR KR1020237001571A patent/KR20230025874A/ko active Pending
- 2021-06-11 WO PCT/US2021/037111 patent/WO2021257409A1/en not_active Ceased
- 2021-06-11 IL IL299015A patent/IL299015A/en unknown
- 2021-06-11 EP EP21737902.3A patent/EP4164678A1/en active Pending
- 2021-06-11 CN CN202180041026.9A patent/CN115916245A/zh active Pending
- 2021-06-11 AU AU2021293021A patent/AU2021293021A1/en active Pending
- 2021-06-11 US US18/009,234 patent/US12533396B2/en active Active
- 2021-06-11 JP JP2022576792A patent/JP2023530112A/ja active Pending
- 2021-06-11 MX MX2022016019A patent/MX2022016019A/es unknown
- 2021-06-15 TW TW110121740A patent/TW202214302A/zh unknown
-
2023
- 2023-01-12 ZA ZA2023/00544A patent/ZA202300544B/en unknown
-
2025
- 2025-12-22 US US19/429,911 patent/US20260216302A1/en active Pending
-
2026
- 2026-04-02 JP JP2026060810A patent/JP2026117025A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sargeant et al. | A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans | |
| JP6612370B2 (ja) | ポンペ病の処置のための投与計画 | |
| Wynne et al. | Oral amrinone in refractory congestive heart failure | |
| US20170260275A1 (en) | Myostatin or activin antagonists for the treatment of sarcopenia | |
| US20110105390A1 (en) | Selection and treatment of patients suffering from wasting | |
| US20070248572A1 (en) | Method for treating diseases with omega interferon | |
| KR100445946B1 (ko) | 폐고혈압 치료법 | |
| RU2387454C2 (ru) | Композиции и способы лечения сердечно-сосудистого заболевания | |
| US20230092769A1 (en) | Combinational therapy comprising glp-1 and/or glp-1 analogs, and insulin and/or insulin analogs | |
| Growdon et al. | L-threonine in the treatment of spasticity | |
| ES2755177T3 (es) | Composición que comprende la proteína HIP/PAP o uno de sus derivados para el tratamiento de la resistencia a la insulina | |
| JP2016535080A (ja) | 療法における使用のためのインスリン様成長因子模倣物 | |
| CN111565740A (zh) | 治疗1型糖尿病和使用胰岛素的2型糖尿病中由运动引起的低血糖 | |
| WO2000062797A1 (en) | Remedies for autonomic neuropathy | |
| Boźović et al. | PLASMA RENIN ACTIVITY IN PATIENTS WITH DISTURBED SYMPATHETIC VASOMOTOR CONTROL (POSTURAL HYPOTENSION) 1 | |
| US20240269146A1 (en) | Use of pelabresib for treating anemias | |
| RU2023100586A (ru) | Композиции и способы лечения болезни помпе с поздним началом | |
| US9352013B2 (en) | Uses of bremelanotide in therapy for female sexual dysfunction | |
| Kopecky et al. | Enalaprilat-enhanced renography in a rat model of renovascular hypertension | |
| JP5274071B2 (ja) | 線維筋痛症治療剤 | |
| CN113616651B (zh) | 一种复方降压药物组合物及其应用 | |
| TW202021610A (zh) | 短胜肽用於治療/預防高血壓及其相關疾病之用途 | |
| KR20090103656A (ko) | 섬유근육통 치료제 | |
| TW201927332A (zh) | aFGF用於預防或治療肌肉耗損相關疾病的用途 | |
| Wang et al. | OS 12-04 Taurine supplementation lowers blood pressure and reduces carotid intima-media thickness in prehypertension |